Atrial fibrillation (AF) is the most common cardiac arrythmia, associated with increased risk of stroke, heart failure, reduced quality of life (QoL), and psychological distress. This randomized controlled trial investigates the effect of MediYoga - a program incorporating deep breathing, low-intensity yoga, and meditation- on disease-specific QoL, blood pressure, and heart rate in 456 patients with paroxysmal AF. With a strong focus on sustainability, the study is fully digital: participants are recruited online, and the 12-week intervention is delivered through an application to smartphone. Additionally, the participants receive online support via Teams. Data will be collected at baseline, 3, 6, and 12 months. The primary outcome is disease specific QoL; secondary outcomes include blood pressure, heart rate, generic QoL, and psychological wellbeing.
Qualitative interviews will explore patients' experiences with the intervention.
Aged 18 and above
Diagnosed with paroxysmal atrial fibrillation
EHRA score at 2 or more
Owner of a smartphone or tablet
Elevated TSH Hormone
Participated in mindfulness or yoga exercise regularly at any point during the last two years.
Herlev and Gentofte Hospital
Lead sponsor
Sophiahemmet
Collaborator